Results 271 to 280 of about 334,593 (294)

Next-generation sequencing for measuring minimal residual disease in AML

Nature Reviews Clinical Oncology, 2018
Roland B Walter, Frederick R Appelbaum
exaly  

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

New England Journal of Medicine, 2018
Allegra A Petti, Christopher A Miller, Jeffery M Klco   +2 more
exaly  

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Nature, 2015
Brian B Liau, Christopher C Ebmeier, Andrei V Krivtsov   +2 more
exaly  

AML-083 AML in Pregnancy: Case Series

Clinical Lymphoma Myeloma and Leukemia
Neha Ganju, Tribikram Panda, Gurleen Oberoi, Mukul Agarwal, Manoranjan Mahapatra   +4 more
openaire   +1 more source

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
Courtney D Dinardo, Naval G Daver, Jessica K Altman   +2 more
exaly  

Regulatory networks in AML

Nature Reviews Cancer, 2018
Katharine H Wrighton
exaly  

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult

Ca-A Cancer Journal for Clinicians, 2002
exaly  

Assessment of Minimal Residual Disease in Standard-Risk AML

New England Journal of Medicine, 2016
Robert K Hills, Michael Griffiths, Rosemary E Gale   +2 more
exaly  

AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis

Nature Medicine, 2004
Motoshi Ichikawa, Takashi Asai, Kinuko Mitani   +2 more
exaly  

AML: Therapy

The Hematology Journal, 2004
openaire   +2 more sources